Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

In vitro anti-influenza activity of in silico repurposed candidate drug Cycrimine.

Matejin S, Bukreyeva N, Radosevic D, Sencanski M, Mantlo E, Veljkovic V, Glisic S, Paessler S.

Antivir Ther. 2020 Feb 28. doi: 10.3851/IMP3348. [Epub ahead of print]

PMID:
32108589
2.

Retraction of: The Effect of a Gender Difference in the Apolipoprotein E Gene DNA Polymorphism on Serum Lipid Levels in a Serbian Healthy Population.

Stanković S, Glišić S, Alavanatić D.

Clin Chem Lab Med. 2020 Feb 25;58(3):e94. doi: 10.1515/cclm-2019-8899. No abstract available.

PMID:
31730520
3.

Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β2-adrenergic receptor (β2-AR).

Sencanski M, Glisic S, Šnajder M, Veljkovic N, Poklar Ulrih N, Mavri J, Vrecl M.

Sci Rep. 2019 Nov 12;9(1):16555. doi: 10.1038/s41598-019-52934-8.

4.

Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.

Jovanović M, Zhukovsky D, Podolski-Renić A, Domračeva I, Žalubovskis R, Senćanski M, Glišić S, Sharoyko V, Tennikova T, Dar'in D, Pešić M, Krasavin M.

Eur J Med Chem. 2019 Nov 1;181:111580. doi: 10.1016/j.ejmech.2019.111580. Epub 2019 Aug 1.

PMID:
31400708
5.

Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets.

Stevanovic S, Sencanski M, Danel M, Menendez C, Belguedj R, Bouraiou A, Nikolic K, Cojean S, Loiseau PM, Glisic S, Baltas M, García-Sosa AT.

Molecules. 2019 Apr 2;24(7). pii: E1282. doi: 10.3390/molecules24071282.

6.

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.

Radosevic D, Sencanski M, Perovic V, Veljkovic N, Prljic J, Veljkovic V, Mantlo E, Bukreyeva N, Paessler S, Glisic S.

Front Cell Infect Microbiol. 2019 Mar 26;9:67. doi: 10.3389/fcimb.2019.00067. eCollection 2019.

7.

Functional characterization of β2-adrenergic and insulin receptor heteromers.

Susec M, Sencanski M, Glisic S, Veljkovic N, Pedersen C, Drinovec L, Stojan J, Nøhr J, Vrecl M.

Neuropharmacology. 2019 Jul 1;152:78-89. doi: 10.1016/j.neuropharm.2019.01.025. Epub 2019 Jan 29.

PMID:
30707913
8.

In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum.

Stevanović S, Perdih A, Senćanski M, Glišić S, Duarte M, Tomás AM, Sena FV, Sousa FM, Pereira MM, Solmajer T.

Molecules. 2018 Mar 27;23(4). pii: E772. doi: 10.3390/molecules23040772.

9.

Identification of Candidate Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor Which May Improve Vagus Nerve Stimulation in Chronic Tinnitus.

Bojić T, Perović VR, Senćanski M, Glišić S.

Front Neurosci. 2017 Nov 14;11:636. doi: 10.3389/fnins.2017.00636. eCollection 2017.

10.

Ibuprofen as a template molecule for drug design against Ebola virus.

Paessler S, Huang C, Sencanski M, Veljkovic N, Perovic V, Glisic S, Veljkovic V.

Front Biosci (Landmark Ed). 2018 Jan 1;23:947-953.

PMID:
28930583
11.

A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy diet.

Veljkovic V, Perovic V, Anderluh M, Paessler S, Veljkovic M, Glisic S, Nicolson G.

F1000Res. 2017 Jan 5;6:13. doi: 10.12688/f1000research.10537.1. eCollection 2017.

12.

Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China.

Veljkovic V, Veljkovic N, Paessler S, Goeijenbier M, Perovic V, Glisic S, Muller CP.

PLoS One. 2016 Nov 9;11(11):e0165451. doi: 10.1371/journal.pone.0165451. eCollection 2016.

13.

An expanded evaluation of protein function prediction methods shows an improvement in accuracy.

Jiang Y, Oron TR, Clark WT, Bankapur AR, D'Andrea D, Lepore R, Funk CS, Kahanda I, Verspoor KM, Ben-Hur A, Koo da CE, Penfold-Brown D, Shasha D, Youngs N, Bonneau R, Lin A, Sahraeian SM, Martelli PL, Profiti G, Casadio R, Cao R, Zhong Z, Cheng J, Altenhoff A, Skunca N, Dessimoz C, Dogan T, Hakala K, Kaewphan S, Mehryary F, Salakoski T, Ginter F, Fang H, Smithers B, Oates M, Gough J, Törönen P, Koskinen P, Holm L, Chen CT, Hsu WL, Bryson K, Cozzetto D, Minneci F, Jones DT, Chapman S, Bkc D, Khan IK, Kihara D, Ofer D, Rappoport N, Stern A, Cibrian-Uhalte E, Denny P, Foulger RE, Hieta R, Legge D, Lovering RC, Magrane M, Melidoni AN, Mutowo-Meullenet P, Pichler K, Shypitsyna A, Li B, Zakeri P, ElShal S, Tranchevent LC, Das S, Dawson NL, Lee D, Lees JG, Sillitoe I, Bhat P, Nepusz T, Romero AE, Sasidharan R, Yang H, Paccanaro A, Gillis J, Sedeño-Cortés AE, Pavlidis P, Feng S, Cejuela JM, Goldberg T, Hamp T, Richter L, Salamov A, Gabaldon T, Marcet-Houben M, Supek F, Gong Q, Ning W, Zhou Y, Tian W, Falda M, Fontana P, Lavezzo E, Toppo S, Ferrari C, Giollo M, Piovesan D, Tosatto SC, Del Pozo A, Fernández JM, Maietta P, Valencia A, Tress ML, Benso A, Di Carlo S, Politano G, Savino A, Rehman HU, Re M, Mesiti M, Valentini G, Bargsten JW, van Dijk AD, Gemovic B, Glisic S, Perovic V, Veljkovic V, Veljkovic N, Almeida-E-Silva DC, Vencio RZ, Sharan M, Vogel J, Kansakar L, Zhang S, Vucetic S, Wang Z, Sternberg MJ, Wass MN, Huntley RP, Martin MJ, O'Donovan C, Robinson PN, Moreau Y, Tramontano A, Babbitt PC, Brenner SE, Linial M, Orengo CA, Rost B, Greene CS, Mooney SD, Friedberg I, Radivojac P.

Genome Biol. 2016 Sep 7;17(1):184. doi: 10.1186/s13059-016-1037-6.

14.

A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.

Vucicevic J, Srdic-Rajic T, Pieroni M, Laurila JM, Perovic V, Tassini S, Azzali E, Costantino G, Glisic S, Agbaba D, Scheinin M, Nikolic K, Radi M, Veljkovic N.

Bioorg Med Chem. 2016 Jul 15;24(14):3174-83. doi: 10.1016/j.bmc.2016.05.043. Epub 2016 May 24.

PMID:
27265687
16.

Arginase Flavonoid Anti-Leishmanial in Silico Inhibitors Flagged against Anti-Targets.

Glisic S, Sencanski M, Perovic V, Stevanovic S, García-Sosa AT.

Molecules. 2016 May 5;21(5). pii: E589. doi: 10.3390/molecules21050589.

17.

Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.

Glišić S, Cavanaugh DP, Chittur KK, Sencanski M, Perovic V, Bojić T.

BMC Bioinformatics. 2016 Mar 22;17:139. doi: 10.1186/s12859-016-0988-7.

18.

The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.

Jovanovic-Cupic S, Glisic S, Stanojevic M, Nozic D, Petrovic N, Mandusic V, Krajnovic M.

Arch Virol. 2016 May;161(5):1189-98. doi: 10.1007/s00705-016-2777-z. Epub 2016 Feb 10.

PMID:
26860912
19.

In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope.

Bojić T, Perović VR, Glišić S.

Front Neurosci. 2016 Jan 21;9:520. doi: 10.3389/fnins.2015.00520. eCollection 2015.

20.

Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic.

Veljkovic V, Paessler S, Glisic S, Prljic J, Perovic VR, Veljkovic N, Scotch M.

Front Microbiol. 2015 Dec 22;6:1456. doi: 10.3389/fmicb.2015.01456. eCollection 2015.

Supplemental Content

Loading ...
Support Center